Positive Trial Data For Achillion By: MarketMinute.com Stock News Shares of Achillion Pharmaceuticals Inc. (Nasdaq: ACHN) soared $1.25 to $3.40 after the drug research company announced positive trial data for its hepatitis drug treatment. Related Stocks: Achison Inc